P12931 (SRC_HUMAN) Homo sapiens (Human)
Proto-oncogene tyrosine-protein kinase Src UniProtKBInterProSTRINGInteractive Modelling
536 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3);
3 identical sequences: Pan troglodytes: K7B763, A0A6D2Y674; Gorilla gorilla gorilla: G3QWW0
Available Structures
72 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal structure of SH3:RGT complex |
Heteromer P05106; | 100 | ||||
| Src-derived mutant peptide inhibitor complex of PTP1B |
Heteromer P18031; | 83.33 | ||||
| Crystal structure of the tyrosine kinase binding domain of Cbl-c in complex with phospho-Src peptide |
Heteromer Q9ULV8; | 100 | 1×CA; | |||
| PTPN21 PTP domain C1108S mutant in complex with SRC pTyr530 peptide |
Heteromer Q16825; | 100 | ||||
| Src-derived peptide inhibitor complex of PTP1B |
Heteromer P18031; | 100 | ||||
| C-Src in complex with compound 9 | homo-2-mer | 100.0 | 2×C0N; | |||
| C-src (SH2 domain) complexed with ace-formyl phosphotyr-glu-(n,n-dipentyl amine) | homo-2-mer | 100 | ||||
| C-SRC (SH2 DOMAIN WITH C188A MUTATION) COMPLEXED WITH ACE-FORMYL PHOSPHOTYR-GLU-(N,N-DIPENTYL AMINE) | homo-2-mer | 99.06 | ||||
| C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-PHOSPHOTYR-GLU-(N,N-DIPENTYL AMINE) | homo-2-mer | 100 | ||||
| C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-MALONYL TYR-GLU-(N,N-DIPENTYL AMINE) | homo-2-mer | 100 | ||||
| C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-PHOSPHOTYR-GLU-(N-ME(-(CH2)3-CYCLOPENTYL)) | homo-2-mer | 100 | ||||
| C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-PHOSPHOTYR-GLU-(3-BUTYLPIPERIDINE) | homo-2-mer | 100 | ||||
| Human cSrc SH3 Domain in complex with Choline Kinase fragment 60-69 | homo-2-mer | 100 | 2×ZN; | |||
| CRYSTAL STRUCTURE OF HUMAN TYROSINE-PROTEIN KINASE C-SRC | monomer | 100.0 | ||||
| Crystal structure of c-Src in complex with covalent inhibitor DC-Srci-6668 | monomer | 100 | 1×JA6; | |||
| Structure of unphosphorylated c-Src in complex with an inhibitor | monomer | 100 | 5×SO4; 1×MPZ; | |||
| Crystal structure of c-Src in complex with covalent inhibitor LW-Srci-8 | monomer | 100 | 1×UJ0; | |||
| CRYSTAL STRUCTURE OF HUMAN TYROSINE-PROTEIN KINASE C-SRC, IN COMPLEX WITH AMP-PNP | monomer | 100 | 1×ANP; | |||
| Structure of Human c-Src Tyrosine Kinase (Thr338Gly Mutant) in Complex with N6-benzyl ADP | monomer | 99.78 | 1×NBS; | |||
| The structure of 1NA in complex with Src T338G | monomer | 99.78 | 1×0J9; | |||
| Src kinase in complex with a quinazoline inhibitor | monomer | 100 | 1×H8H; | |||
| Crystal structure of Src kinase domain in complex with Purvalanol A | monomer | 99.23 | 1×P01; | |||
| Crystal structure of Src kinase domain in complex with CGP77675 | monomer | 99.22 | 1×S03; | |||
| Src kinase bound to eCF506 trapped in inactive conformation | monomer | 100.0 | 1×EDO; 1×UCW; | |||
| human Src kinase bound to kinase inhibitor bosutinib | monomer | 100.0 | 1×DB8; | |||
| The complex of Src with GW8510 | monomer | 100.0 | 1×L1N; | |||
| SRC kinase bound to covalent inhibitor | monomer | 100.0 | 1×6H3; | |||
| Src M314L T338M double mutant bound to kinase inhibitor bosutinib | monomer | 99.25 | 1×DB8; | |||
| Src M314L T338M double mutant bound to kinase inhibitor bosutinib | monomer | 99.25 | 1×DB8; | |||
| Human Src A403T mutant bound to kinase inhibitor bosutinib | monomer | 99.62 | 1×DB8; | |||
| C-term tail segment of human tyrosine kinase (258-533) | monomer | 100 | ||||
| DGY-06-116, a novel and selective covalent inhibitor of SRC kinase | monomer | 100.0 | 1×HVY; | |||
| Src Kinase Domain in complex with ponatinib | monomer | 100.0 | 1×0LI; 1×TRS; 4×GOL; | |||
| Crystal structure of Src kinase domain | monomer | 99.14 | ||||
| Src kinase in complex with inhibitor AP23451 | monomer | 100.0 | 1×24A; | |||
| Src kinase in complex with inhibitor AP23464 | monomer | 100.0 | 1×HET; | |||
| Structure of human SRC regulatory domains in complex with the C-terminal PRRP motifs of GPR54. | monomer | 100 | ||||
| Triple mutant Src SH2 domain bound to phosphotyrosine | monomer | 97.22 | 1×PTR; | |||
| Triple mutant Src SH2 domain | monomer | 97.22 | ||||
| Triple mutant Src SH2 domain bound to phosphate ion | monomer | 97.22 | 1×PO4; | |||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU82197. | monomer | 100 | 1×197; | |||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU82129. | monomer | 100 | 1×821; | |||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH DPI59. | monomer | 100 | 1×I59; | |||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU85053. | monomer | 100 | 1×853; | |||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH PASBN. | monomer | 100 | 1×PSN; | |||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH OXALIC ACID. | monomer | 100 | 1×OXD; | |||
| Crystal structure of sh2 in complex with ru85052 | monomer | 100 | 1×852; | |||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU85493. | monomer | 100 | 1×493; | |||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH PHENYLPHOSPHATE. | monomer | 100 | 2×HPS; | |||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH ISO24. | monomer | 100 | 1×IS2; | |||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU78300. | monomer | 100 | 1×300; | |||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU81843. | monomer | 100 | 1×843; | |||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU79256. | monomer | 100 | 1×256; | |||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH PAS219. | monomer | 100 | 1×219; | |||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU84687. | monomer | 100 | 1×687; | |||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU82209. | monomer | 100 | 1×822; | |||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU83876. | monomer | 100 | 1×876; | |||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU78299. | monomer | 100 | 1×299; | |||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU90395. | monomer | 100 | 1×903; | |||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU79072. | monomer | 100 | 1×772; | |||
| NMR STRUCTURE OF THE HUMAN SRC SH2 DOMAIN COMPLEX | monomer | 100 | ||||
| NMR STRUCTURE OF THE HUMAN SRC SH2 DOMAIN COMPLEX | monomer | 100 | ||||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU78783. | monomer | 100 | 1×787; | |||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH MALONICACID. | monomer | 100 | 1×MLA; | |||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH FRAGMENT2. | monomer | 100 | 1×CIT; | |||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH PHOSPHATE. | monomer | 100 | 1×PO4; | |||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU78262. | monomer | 100 | 1×262; | |||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU78791. | monomer | 100 | 1×791; | |||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU79073. | monomer | 100 | 1×790; | |||
| PEPTIDE INHIBITORS OF SRC SH3-SH2-PHOSPHOPROTEIN INTERACTIONS | monomer | 100.0 | ||||
| C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-DIFLUORO PHOSPHOTYR-GLU-(N,N-DIPENTYL AMINE) | monomer | 100 | ||||
| Crystal structure of a superbinder Src SH2 domain (sSrcF) in complex with a high affinity phosphope… | monomer | 91.67 | 1×ZN; | |||
2 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 2h8h.1.A | monomer | 0.83 | 1×H8H; | 100.00 | ||
| 1y57.1.A | monomer | 0.82 | 1×MPZ; | 100.00 | ||
4 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 2h8h.1.A | monomer | 0.81 | 1×H8H; | 100.00 | ||
| Isoform 2 | 1y57.1.A | monomer | 0.80 | 1×MPZ; | 100.00 | ||
| Isoform 3 | 1y57.1.A | monomer | 0.79 | 1×MPZ; | 100.00 | ||
| Isoform 3 | 2h8h.1.A | monomer | 0.79 | 1×H8H; | 100.00 | ||